To get a sense of who is truly in control of Alcon Inc. ( VTX:ALC ), it is important to understand the ownership structure of ...

Alcon Inc.’s ALC growth is driven by its robust Surgical business. The performance of the Vision Care arm also appears encouraging. However, concerns remain about the macroeconomic headwinds ...

David Endicott, Alcon CEO World Sight Day 2024 focuses on the importance of eye care in young people. As the CEO of the ...

Alcon ALC has been gaining from a strong pipeline and its focus on research and innovation. Market share gains also aid ...

Alcon (ALC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on September 13. Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on the ...

Medical device peers Alcon, Cooper Cos. and Johnson & Johnson own 25% to 40% of the market for contact lenses vs. 10% for Bausch + Lomb. In pharmaceuticals, AbbVie would encounter antitrust ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Cooper’s pricing power and cost optimization efforts are expected to drive margin expansion. Read why I reiterate a Buy ...

Faricimab, a humanized, bispecific, immunoglobulin G monoclonal antibody, received FDA approval as an intravitreal injection ...

In a report released on October 10, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...